Literature DB >> 21830136

Quantification of total and free concentrations of R- and S-warfarin in human plasma by ultrafiltration and LC-MS/MS.

Berit Packert Jensen1, Paul Ken Leong Chin, Evan James Begg.   

Abstract

A sensitive LC-MS/MS assay for quantification of total and free concentrations of R- and S-warfarin in plasma was required to support clinical studies on warfarin enantiomers. Several ultrafiltration devices were evaluated for separation of free warfarin from plasma proteins. The highest precision and lowest non-specific binding was obtained for Centrifree ultrafiltration devices. R- and S-warfarin were extracted from plasma (total) and ultrafiltrate (free) by liquid-liquid extraction with methyl tert-butyl ether using d(6)-warfarin as internal standard. Mean extraction recovery was 68 ± 4%. The enantiomers were separated on a Chirobiotic V column with isocratic elution using 40% methanol and 0.03% acetic acid in water. Negative mode electrospray ionisation was used for MS/MS detection, monitoring the ion transition m/z 307/161. Calibration curves (quadratic, weighted 1/x) were fitted over the range of 20-2,000 ng/ml (r(2)≥0.995) in plasma and 0.5-20 ng/ml (r(2)≥0.998) in ultrafiltrate. The lower limit of quantification for R- and S-warfarin was 0.5 ng/ml in ultrafiltrate. Intra- and interday precision (% RSD) and bias were within 10% in all cases, and matrix effects were negligible. The assay was applied successfully to analysis of samples from clinical studies. © Springer-Verlag 2011

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21830136     DOI: 10.1007/s00216-011-5303-x

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  7 in total

1.  Influence of adult age on the total and free clearance and protein binding of (R)- and (S)-warfarin.

Authors:  Berit Packert Jensen; Paul Ken Leong Chin; Rebecca Lee Roberts; Evan James Begg
Journal:  Br J Clin Pharmacol       Date:  2012-11       Impact factor: 4.335

2.  The pharmacokinetics and pharmacodynamics of single dose (R)- and (S)-warfarin administered separately and together: relationship to VKORC1 genotype.

Authors:  John Maddison; Andrew A Somogyi; Berit P Jensen; Heather M James; Melanie Gentgall; Paul E Rolan
Journal:  Br J Clin Pharmacol       Date:  2013-01       Impact factor: 4.335

3.  Monitoring the distribution of warfarin in blood plasma.

Authors:  Annika M Rosengren; Björn C G Karlsson; Ian A Nicholls
Journal:  ACS Med Chem Lett       Date:  2012-06-20       Impact factor: 4.345

4.  Development of a chiral micellar electrokinetic chromatography-tandem mass spectrometry assay for simultaneous analysis of warfarin and hydroxywarfarin metabolites: application to the analysis of patients serum samples.

Authors:  Xiaochun Wang; Jingguo Hou; Michael Jann; Yuen Yi Hon; Shahab A Shamsi
Journal:  J Chromatogr A       Date:  2012-11-26       Impact factor: 4.759

5.  Validation and Application of a Simple UHPLC-MS-MS Method for the Enantiospecific Determination of Warfarin in Human Urine.

Authors:  Osama Y Alshogran; Andrew J Ocque; François A Leblond; Vincent Pichette; Thomas D Nolin
Journal:  J Chromatogr Sci       Date:  2015-12-11       Impact factor: 1.618

6.  Optimization and validation of a capillary electrophoresis laser-induced fluorescence method for amino acids determination in human plasma: application to bipolar disorder study.

Authors:  Ma Paz Lorenzo; Alma Villaseñor; Anuradha Ramamoorthy; Antonia Garcia
Journal:  Electrophoresis       Date:  2013-05-08       Impact factor: 3.535

7.  Responsiveness to low-dose warfarin associated with genetic variants of VKORC1, CYP2C9, CYP2C19, and CYP4F2 in an Indonesian population.

Authors:  T Rusdiana; T Araki; T Nakamura; A Subarnas; K Yamamoto
Journal:  Eur J Clin Pharmacol       Date:  2012-08-02       Impact factor: 2.953

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.